Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lidocaine/tetracaine topical cream - Crescita Therapeutics

Drug Profile

Lidocaine/tetracaine topical cream - Crescita Therapeutics

Alternative Names: Flexicaine; Pliaglis; S-Caine™ Peel; Tetracaine/lidocaine topical cream - Crescita Therapeutics

Latest Information Update: 07 Nov 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ZARS
  • Developer Crescita Therapeutics; Galderma; Nuvo Research
  • Class Acetanilides; Aminobenzoic acids; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Procedural pain
  • Phase II Unspecified
  • Discontinued Postherpetic neuralgia

Most Recent Events

  • 05 Nov 2019 Crescita Therapeutics files for patent protection of supplemental protection of alternate enhanced versions of lidocaine/tetracaine (Pliaglis®) in USA
  • 05 Nov 2019 The US FDA recommends approval of Enhanced formulation of lidocaine/tetracaine for Procedural pain (Prevention) in USA
  • 16 Jul 2019 Crescita Therapeutics has patent protection for solid-forming formulations of lidocaine/tetracaine (Pliaglis®) in USA, Mexico, Canada, Australia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top